Survival Without Adjuvant Therapy for Low-Risk Endometrial Cancer With Isolated Tumor Cells

JAMA Oncology 2026 Open access

Read full text
Authors: Koji Matsuo, Matthew W. Lee, Emmeline Friedman, Hadi Erfani, Alexia J. Ouzounian, Jennifer A Yao, Naoko Komura, Yoshikazu Nagase, Shinya Matsuzaki, Michiko Kodama, Hiroyuki Kanao, Lynda D. Roman
DOI: 10.1001/jamaoncol.2026.0170
Cited by: 2
References: 3

Abstract

This cohort study assesses overall survival without adjuvant therapy in patients with uterine factor–based low-risk endometrial cancer who had isolated tumor cells present in regional lymph nodes.

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Gynecological conditions and treatments Ovarian cancer diagnosis and treatment

Publication details

Journal / source
JAMA Oncology
Publisher
American Medical Association (AMA)
Volume
12
Issue
5
Pages
528–528
Publication date
12 March 2026
Language
EN